NCT01650298终止不适用
Pilot Study: Tailored Anticoagulation for Noncontinuous AF
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 64
- 试验地点
- 20
- 主要终点
- Total Cumulative Days on Anticoagulation
研究概览
简要总结
The purpose of this study is to determine whether it is safe to stop anticoagulation medication in patients with a history of atrial fibrillation (AF) based on information from a pacemaker or implantable cardioverter defibrillator (ICD).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient has a St Jude Medial device that is compatible with Merlin.net (remote monitoring)
- •Patient has history of atrial fibrillation (non-continuous)
- •Patient must be taking a a blood thinner medication other than warfarin or aspirin for atrial fibrillation
- •Patient is willing to complete a questionnaire
排除标准
- •Patient is in atrial fibrillation all of the time
- •Patient has a history of stroke or blood clot
- •Patient is on warfarin or coumadin
- •Patient cannot be taken off of his blood thinner medication due to another medical condition
- •Patient is not capable of sending a remote device transmission to doctor once a week
结局指标
主要结局
Total Cumulative Days on Anticoagulation
时间窗: one year
To assess the reduction in time on anticoagulation, the cumulative total number of days on anticoagulation for each group throughout the follow-up period was determined. This study was designed as a pilot/feasibility study and therefore was not powered to detect thromboembolic events. Per study protocol, all patients completed a 30 day run-in period following enrollment during which anticoagulation could not be stopped regardless of AT/AF burden.
次要结局
未报告次要终点
研究者
研究点 (20)
Loading locations...
相似试验
终止
4 期
Oral Anticoagulation Therapy Pilot StudyParoxysmal Atrial FibrillationNCT01959425Biosense Webster, Inc.80
终止
不适用
A trial to determine if withholding anticoagulation is not worse than standard anticoagulation therapy in the treatment of blood clots in the lungsIsolated or incidental subsegmental pulmonary embolismCirculatory SystemPulmonary embolismISRCTN15645679niversity of Birmingham1,466
招募中
不适用
Randomized study of anti-coagulant therapy to preventpostoperative deep venous thrombosis/pulmonary embolismPatients after diegstive surgery classified high risk in DVT/PE prevention guide lineJPRN-UMIN000002444unversity of tokushima, surgery300
已完成
2 期
Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With EdoxabanAnticoagulation ReversalNCT02207257Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.65
已完成
不适用
Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial FibrillationAtrial FibrillationNCT05262322Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company234